Johnson & Johnson (JNJ) Shareholder Dowling & Yahnke Upped Stake by $1.62 Million; Ftb Advisors Has Decreased Its Starbucks (SBUX) Stake as Valuation Rose

Starbucks Corporation (NASDAQ:SBUX) Logo

Ftb Advisors Inc decreased its stake in Starbucks Corp (SBUX) by 20.16% based on its latest 2018Q3 regulatory filing with the SEC. Ftb Advisors Inc sold 1,009 shares as the company’s stock rose 19.14% while stock markets declined. The institutional investor held 3,997 shares of the restaurants company at the end of 2018Q3, valued at $1.45M, down from 5,006 at the end of the previous reported quarter. Ftb Advisors Inc who had been investing in Starbucks Corp for a number of months, seems to be less bullish one the $81.78B market cap company. The stock increased 0.66% or $0.43 during the last trading session, reaching $65.92. About 10.82 million shares traded. Starbucks Corporation (NASDAQ:SBUX) has risen 10.74% since December 11, 2017 and is uptrending. It has outperformed by 10.74% the S&P500. Some Historical SBUX News: 29/05/2018 – Pret A Manger Overshadowed by Starbucks But It Sees Growth Ahead; 12/03/2018 – STARBUCKS TO LICENSE RETAILS OPS IN BRAZIL TO SOUTHROCK; 19/05/2018 – Vox: Starbucks says everyone’s a customer after Philadelphia bias incident; 16/04/2018 – Detailed Research: Economic Perspectives on United States Steel, Zoe’s Kitchen, First Horizon National, Starbucks, Nuance Commu; 07/05/2018 – Starbucks CEO Kevin Johnson says its $7.15 billion deal with food giant Nestle should return value to shareholders; 07/05/2018 – Nestle to pay $7.15 bln to Starbucks to jump-start coffee business; 11/05/2018 – Nestlé agrees $7.2bn tie-up to sell Starbucks products; 17/04/2018 – STARBUCKS CORP SBUX.O SAYS WILL CLOSE ALL U.S. STORES FOR RACIAL-BIAS EDUCATION ON MAY 29; 29/03/2018 – Starbucks gets downgraded as analyst predicts weaker-than-expected China sales; 18/04/2018 – May 29 will mark the second time that Starbucks has closed its stores for an afternoon

Dowling & Yahnke Llc increased its stake in Johnson & Johnson (JNJ) by 15.18% based on its latest 2018Q3 regulatory filing with the SEC. Dowling & Yahnke Llc bought 11,715 shares as the company’s stock rose 5.87% while stock markets declined. The institutional investor held 88,870 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $12.28 million, up from 77,155 at the end of the previous reported quarter. Dowling & Yahnke Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $392.96B market cap company. The stock increased 0.87% or $1.26 during the last trading session, reaching $146.52. About 7.08 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 3.75% since December 11, 2017 and is uptrending. It has outperformed by 3.75% the S&P500. Some Historical JNJ News: 30/05/2018 – JANSSEN SAYS PLANNED START OF PHASE 1B/2 STUDY FOR MULTIPLE MYELOMA IS SCHEDULED TO BEGIN ENROLLMENT IN SECOND HALF OF 2018; 16/03/2018 – J&J – RECEIVED A BINDING OFFER FROM PLATINUM EQUITY, A LEADING PRIVATE INVESTMENT FIRM, TO ACQUIRE ITS LIFESCAN BUSINESS FOR APPROXIMATELY $2.1 BLN; 29/03/2018 – lnvokana (canagliflozin; Johnson & Johnson/Mitsubishi Tanabe/Daiichi Sankyo) Drug Analysis 2018 – ResearchAndMarkets.com; 18/04/2018 – KENTUCKY SUES JOHNSON & JOHNSON, ACCUSES COMPANY OF DEVISING DECEPTIVE OPIOID MARKETING SCHEME; 16/03/2018 – Johnson & Johnson: LifeScan Had 2017 Net Revenue of About $1.5B; 16/04/2018 – JANSSEN – COS TO SHARE DEVELOPMENT COSTS, COMMERCIAL PROFITS AND LOSSES; ADDITIONAL TERMS OF AGREEMENT NOT DISCLOSED; 26/03/2018 – Hartford Dividend and Growth Adds AT&T, Cuts J&J; 21/05/2018 – J&J GETS FDA CLEARANCE FOR EMBOTRAP II STENT RETRIEVER DEVICE; 29/05/2018 – Novo Nordisk’s experimental diabetes pill proved better at lowering blood sugar levels than Eli Lilly and Boehringer Ingelheim’s established Jardiance; 14/03/2018 – South Dakota sues opioid makers as litigation swells

Investors sentiment increased to 1.05 in 2018 Q3. Its up 0.08, from 0.97 in 2018Q2. It increased, as 43 investors sold JNJ shares while 748 reduced holdings. 115 funds opened positions while 719 raised stakes. 1.70 billion shares or 7.91% less from 1.84 billion shares in 2018Q2 were reported. Litman Gregory Asset Mgmt Ltd Liability Corp stated it has 0.01% in Johnson & Johnson (NYSE:JNJ). Acg Wealth has 0.97% invested in Johnson & Johnson (NYSE:JNJ). 35,692 were reported by Tt. Welch Grp holds 198,600 shares or 2.86% of its portfolio. National Bank & Trust Of The West accumulated 23,058 shares. Thomas Story And Son Limited accumulated 86,588 shares or 6.33% of the stock. Northwestern Mutual Wealth Mngmt Company reported 481,516 shares. Wilbanks Smith And Thomas Asset Mngmt Ltd holds 0.8% or 95,635 shares. A D Beadell Counsel accumulated 4.02% or 34,493 shares. Camelot Portfolios Lc holds 1,516 shares or 0.09% of its portfolio. 21,674 were accumulated by Sfe Inv Counsel. Cypress Grp reported 2.26% of its portfolio in Johnson & Johnson (NYSE:JNJ). Lvm Capital Mngmt Mi owns 120,625 shares or 3.81% of their US portfolio. Bnp Paribas Arbitrage, New York-based fund reported 1.74 million shares. Diamond Hill Mgmt, a Ohio-based fund reported 2,037 shares.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Johnson & Johnson (JNJ) Management Presents at Citi’s 2018 Global Healthcare Conference (Transcript) – Seeking Alpha” on December 05, 2018, also Fool.com with their article: “Here’s Why BeiGene Stock Rose 21.7% in November – The Motley Fool” published on December 09, 2018, Investorplace.com published: “Why Is Shopify Stock Holding Up While Others Can’t Handle The Turmoil? – Investorplace.com” on December 11, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Is Johnson & Johnson A Buy Here? – Seeking Alpha” published on November 19, 2018 as well as Fool.com‘s news article titled: “Why Johnson & Johnson’s Up 3% So Far in 2018 – Motley Fool” with publication date: November 15, 2018.

Dowling & Yahnke Llc, which manages about $2.91B and $1.15B US Long portfolio, decreased its stake in Reliance Steel & Aluminum Co (NYSE:RS) by 6,200 shares to 457,391 shares, valued at $39.01 million in 2018Q3, according to the filing. It also reduced its holding in Apple Inc (NASDAQ:AAPL) by 3,328 shares in the quarter, leaving it with 127,503 shares, and cut its stake in Realty Income Corp (NYSE:O).

Among 25 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 4 Sell and 9 Hold. Therefore 48% are positive. Johnson & Johnson has $170.0 highest and $90 lowest target. $137.42’s average target is -6.21% below currents $146.52 stock price. Johnson & Johnson had 108 analyst reports since August 7, 2015 according to SRatingsIntel. BTIG Research downgraded Johnson & Johnson (NYSE:JNJ) on Friday, July 21 to “Sell” rating. As per Tuesday, July 18, the company rating was maintained by BMO Capital Markets. Deutsche Bank upgraded the shares of JNJ in report on Tuesday, September 29 to “Buy” rating. UBS maintained it with “Buy” rating and $148.0 target in Thursday, August 31 report. The firm has “Neutral” rating given on Wednesday, April 20 by Goldman Sachs. On Tuesday, February 6 the stock rating was maintained by Wells Fargo with “Buy”. Stifel Nicolaus maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, October 18 with “Hold” rating. Jefferies maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, October 18 with “Buy” rating. Jefferies upgraded Johnson & Johnson (NYSE:JNJ) on Wednesday, October 11 to “Buy” rating. The firm has “Buy” rating given on Friday, January 12 by Wells Fargo.

Since August 27, 2018, it had 0 buys, and 7 selling transactions for $79.41 million activity. The insider Sneed Michael E sold $4.41M. Another trade for 264,465 shares valued at $38.60M was sold by Gorsky Alex. Duato Joaquin had sold 40,000 shares worth $5.77M. Fasolo Peter sold 166,695 shares worth $24.41 million.

More notable recent Starbucks Corporation (NASDAQ:SBUX) news were published by: Fool.com which released: “2 Dividend Stocks to Buy in December – Motley Fool” on December 06, 2018, also Seekingalpha.com with their article: “Starbucks: Time To Re-Evaluate – Seeking Alpha” published on November 14, 2018, Bizjournals.com published: “Starbucks game’s top prize: 30 years of free coffee – Bizwomen – The Business Journals” on November 28, 2018. More interesting news about Starbucks Corporation (NASDAQ:SBUX) were released by: Investorplace.com and their article: “7 S&P 500 Stocks to Buy Trading Within 10% of an All-Time High – Investorplace.com” published on December 07, 2018 as well as Nasdaq.com‘s news article titled: “BOJA vs. SBUX: Which Stock Should Value Investors Buy Now? – Nasdaq” with publication date: November 16, 2018.

Since August 3, 2018, it had 1 insider buy, and 4 sales for $15.56 million activity. 166,666 shares were sold by TERUEL JAVIER G, worth $8.78M on Friday, August 24. BREWER ROSALIND G also bought $270,200 worth of Starbucks Corporation (NASDAQ:SBUX) on Monday, August 20.

Investors sentiment increased to 0.79 in Q3 2018. Its up 0.03, from 0.76 in 2018Q2. It improved, as 78 investors sold SBUX shares while 489 reduced holdings. 128 funds opened positions while 322 raised stakes. 905.08 million shares or 2.60% less from 929.26 million shares in 2018Q2 were reported. Rand Wealth Ltd Liability reported 35,400 shares. Norris Perne & French Ltd Liability Partnership Mi reported 89,554 shares stake. Palladium Ltd Liability Corp has invested 0.81% of its portfolio in Starbucks Corporation (NASDAQ:SBUX). Barclays Plc holds 0.15% or 3.72 million shares. United Fincl Advisers Ltd Liability Corporation holds 1.69 million shares or 0.67% of its portfolio. The Washington-based Merriman Wealth Ltd has invested 0.38% in Starbucks Corporation (NASDAQ:SBUX). 1St Source Bank reported 0.15% stake. Moreover, Zacks Investment has 0.22% invested in Starbucks Corporation (NASDAQ:SBUX) for 182,482 shares. Force Cap Mgmt Limited Liability reported 0.87% stake. Koshinski Asset Management has 0.09% invested in Starbucks Corporation (NASDAQ:SBUX) for 10,599 shares. Donaldson Cap Lc accumulated 491,069 shares. Mckinley Carter Wealth Services has invested 0.76% of its portfolio in Starbucks Corporation (NASDAQ:SBUX). Coldstream Management reported 211,258 shares. Willingdon Wealth Mgmt has invested 0% in Starbucks Corporation (NASDAQ:SBUX). Telemus Cap Ltd Liability Co owns 4,152 shares for 0.02% of their portfolio.

Among 41 analysts covering Starbucks Corporation (NASDAQ:SBUX), 24 have Buy rating, 0 Sell and 17 Hold. Therefore 59% are positive. Starbucks Corporation has $81 highest and $48 lowest target. $64.83’s average target is -1.65% below currents $65.92 stock price. Starbucks Corporation had 136 analyst reports since July 28, 2015 according to SRatingsIntel. BTIG Research downgraded the shares of SBUX in report on Wednesday, June 20 to “Hold” rating. The firm has “Hold” rating given on Thursday, January 25 by BMO Capital Markets. The rating was downgraded by BMO Capital Markets to “Market Perform” on Wednesday, August 9. The firm has “Buy” rating given on Monday, February 5 by Piper Jaffray. The firm has “Hold” rating given on Tuesday, January 16 by Barclays Capital. The stock has “Outperform” rating by Wedbush on Friday, July 22. The stock of Starbucks Corporation (NASDAQ:SBUX) has “Buy” rating given on Tuesday, June 13 by Jefferies. The rating was maintained by Mizuho with “Buy” on Thursday, September 28. The stock has “Buy” rating by Cowen & Co on Friday, July 28. The firm earned “Market Perform” rating on Wednesday, June 20 by BMO Capital Markets.

Analysts await Starbucks Corporation (NASDAQ:SBUX) to report earnings on January, 24. They expect $0.64 earnings per share, down 1.54% or $0.01 from last year’s $0.65 per share. SBUX’s profit will be $793.98M for 25.75 P/E if the $0.64 EPS becomes a reality. After $0.62 actual earnings per share reported by Starbucks Corporation for the previous quarter, Wall Street now forecasts 3.23% EPS growth.

Starbucks Corporation (NASDAQ:SBUX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.